WVE Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $2.27M ; Research and development $51.29M ; Operating expenses $76.07M ; Income tax $0.00 . 2026-03-31: Revenue $38.25M ; Research and development $47.44M ; Operating expenses $69.54M ; Income tax $0.00 . 2025-12-31: Revenue (m) ; Research and development $52.81M* ; Operating expenses $73.71M* ; Income tax $0.00* . 2025-09-30: Revenue (m) ; Research and development $45.87M ; Operating expenses $63.96M ; Income tax $0.00 . Type Of Arrangement Separate filed amounts; connecting flows are not established. Components and totals may overlap.
WVE revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Gsk Collaboration Agreement $2.30M Revenue $2.27M Operating expenses $76.07M Operating income -$73.80M Other income, net -$275.00K Research & development $51.29M Pre-tax income -$69.36M Income tax $0.00 Net income -$69.36M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-06-30 $2.27M $51.29M $76.07M $0.00 -$69.36M 2026-03-31 $38.25M $47.44M $69.54M $0.00 -$26.09M 2025-12-31 (m) $52.81M* $73.71M* $0.00* -$53.18M* 2025-09-30 (m) $45.87M $63.96M $0.00 -$53.85M 2025-06-30 $8.70M $43.47M $61.46M $0.00 -$50.47M 2025-03-31 $9.18M $40.62M $58.98M $0.00 -$46.88M 2024-09-30 (m) $41.20M $56.24M $0.00 -$61.78M 2024-06-30 $19.69M $40.39M $54.69M $0.00 -$32.92M 2024-03-31 $12.54M $33.45M $47.00M $0.00 -$31.56M 2023-09-30 $49.21M $31.64M $44.77M -$677.00K $7.25M 2023-06-30 $22.11M $33.31M $45.58M $0.00 -$21.10M 2023-03-31 $12.93M $30.98M $43.21M $0.00 -$27.41M 2022-09-30 $285.00K $27.57M $39.18M $0.00 -$39.00M 2022-06-30 $375.00K $29.73M $42.54M $0.00 -$41.30M 2022-03-31 $1.75M $27.47M $39.84M $0.00 -$37.81M 2021-09-30 $36.42M $31.09M $44.03M $0.00 -$6.23M 2021-06-30 $2.78M $31.64M $42.60M $0.00 -$38.77M 2021-03-31 (m) $33.39M $43.47M $0.00 -$42.46M 2020-09-30 $3.45M $28.27M $37.87M $0.00 -$33.10M 2020-06-30 $3.03M $31.48M $41.68M $0.00 -$40.53M 2020-03-31 $4.16M $41.16M $54.15M $0.00 -$47.49M 2019-12-31 $2.40M (m) $62.93M (m) -$56.77M 2019-09-30 $2.93M $44.59M $57.11M $0.00 -$50.73M 2019-06-30 $7.63M $41.60M $53.24M $0.00 -$41.94M 2019-03-31 $3.03M $40.11M $51.01M $0.00 -$44.20M 2018-12-31 $3.62M (m) $52.56M (m) -$37.89M 2018-09-30 $4.49M $32.88M $42.73M $0.00 -$37.63M 2018-06-30 $4.88M $32.55M $41.45M $0.00 -$35.89M 2018-03-31 $1.42M $29.20M $37.20M $172.00K -$35.24M 2017-12-31 $1.10M (m) $32.26M (m) -$30.79M 2017-09-30 $1.31M $20.10M $27.67M -$418.00K -$25.49M 2017-06-30 $1.10M $19.10M $25.77M $343.00K -$24.60M 2017-03-31 $383.00K $14.74M $20.59M $1.11M -$21.10M 2016-12-31 $676.00K (m) $19.18M (m) -$18.45M 2016-09-30 $392.00K $13.69M $17.63M $384.00K -$17.54M 2016-06-30 $417.00K $8.40M $12.05M $48.00K -$11.56M 2016-03-31 (m) $4.74M $7.95M -$5.00K -$7.85M 2015-12-31 (m) (m) $7.21M (m) -$7.10M 2015-09-30 (m) $2.13M $4.99M $83.00K -$4.94M 2015-06-30 $126.00K $1.85M $3.75M $49.00K -$3.70M 2015-03-31 $26.00K $1.61M $3.49M $50.00K -$3.46M 2014-12-31 (m) (m) $1.78M (m) -$1.75M 2014-09-30 (m) $585.00K $1.35M $34.00K -$1.36M 2014-06-30 (m) (m) $1.29M (m) -$1.72M 2014-03-31 (m) (m) $968.00K (m) -$400.00K
Revenue and expense 6 month Period end Revenue Research and development Operating expenses Income tax Net income 2026-06-30 $40.52M $98.73M $145.62M $0.00 -$95.44M 2025-06-30 $17.87M $84.09M $120.44M $0.00 -$97.35M 2024-06-30 $32.23M $73.84M $101.69M $0.00 -$64.48M 2023-06-30 $35.03M $64.29M $88.79M $0.00 -$48.51M 2022-06-30 $2.13M $57.20M $82.38M $0.00 -$79.11M 2021-06-30 $2.78M $65.03M $86.08M $0.00 -$81.23M 2020-06-30 $7.19M $72.64M $95.84M $0.00 -$88.02M 2019-06-30 $10.65M $81.72M $104.26M $0.00 -$86.14M 2018-06-30 $6.30M $61.74M $78.65M $172.00K -$71.14M 2017-06-30 $1.48M $33.84M $46.36M $1.45M -$45.69M 2016-06-30 $417.00K $13.14M $20.01M $43.00K -$19.41M 2015-06-30 $152.00K $3.46M $7.25M $99.00K -$7.17M
Revenue and expense 9 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-09-30 (m) $129.97M $184.40M $0.00 -$151.20M 2024-09-30 (m) $115.04M $157.92M $0.00 -$126.26M 2023-09-30 $84.25M $95.94M $133.56M -$677.00K -$41.26M 2022-09-30 $2.41M $84.78M $121.57M $0.00 -$118.11M 2021-09-30 $39.20M $96.11M $130.10M $0.00 -$87.46M 2020-09-30 $10.64M $100.91M $133.70M $0.00 -$121.12M 2019-09-30 $13.58M $126.30M $161.37M $0.00 -$136.87M 2018-09-30 $10.79M $94.62M $121.37M $172.00K -$108.77M 2017-09-30 $2.79M $53.94M $74.03M $1.03M -$71.19M 2016-09-30 $809.00K $26.82M $37.63M $427.00K -$36.95M 2015-09-30 $152.00K $5.59M $12.24M $182.00K -$12.10M 2014-09-30 (m) $1.67M $3.61M $94.00K -$3.48M
Revenue and expense 12 month Period end Revenue Research and development Operating expenses Income tax Net income 2025-12-31 $42.73M $182.78M $258.11M $0.00 -$204.38M 2024-12-31 $108.30M $159.68M $218.71M $0.00 -$97.01M 2023-12-31 $113.31M $130.01M $181.30M -$677.00K -$57.51M 2022-12-31 $3.65M $115.86M $166.37M $681.00K -$161.82M 2021-12-31 $40.96M $121.88M $167.98M -$204.00K -$122.25M 2020-12-31 $20.08M $130.94M $173.45M -$841.00K -$149.91M 2019-12-31 $15.98M $175.43M $224.30M $0.00 -$193.64M 2018-12-31 $14.41M $134.43M $173.94M $69.00K -$146.65M 2017-12-31 $3.89M $79.31M $106.28M $842.00K -$101.98M 2016-12-31 $1.09M $40.82M $56.81M $482.00K -$55.66M 2015-12-31 $152.00K $9.06M $19.45M $44.00K -$19.20M 2014-12-31 (m) $2.40M $5.39M $84.00K -$5.23M 2013-12-31 (m) $1.92M $3.57M -$330.00K -$3.32M